HIGHLIGHTS
- What: The departure of pharmaceutical companies from Nigeria threatens local and regional public health, potentially exacerbating AMR.
- Who: Chiamaka Norah Ezeagu from the pharmaceutical companies from Nigeria have published the research: The impact of the exodus of big pharmaceutical companies from Nigeria on antimicrobial resistance in the West African subregion, in the Journal: (JOURNAL)
SUMMARY
The exit of GlaxoSmithKline (GSK) and Sanofi from Nigeria could potentiate the risk of antimicrobial resistance (AMR) in the country and West Africa subregion. The big pharmaceutical companies play significant roles in antibiotics development and marketing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.